Table 2.
The diagnosis values of CCL20 and AFP.
| Biomarkers | Cut-off | AUC (95%CI) | Sensitivity (%) | Specificity (%) | PPV (%) | NPV (%) |
|---|---|---|---|---|---|---|
| HCC versus healthy control | ||||||
| AFP | 7.55 | 0.9581(0.9254–0.9908) | 82.89 | 97.37 | 98.44 | 74 |
| CCL20 | 15.43 | 0.8591(0.7932–0.9250) | 73.42 | 86.84 | 92.06 | 61.11 |
| Combination | 10.34 | 0.9675(0.9411–0.9938) | 88.16 | 97.37 | 98.53 | 80.43 |
| HCC versus non-HCC | ||||||
| AFP | 7.55 | 0.9171(0.8769–0.9573) | 82.89 | 86.6 | 82.89 | 86.6 |
| CCL20 | 23.37 | 0.7141(0.6385–0.7897) | 67.09 | 70.1 | 65.43 | 72.34 |
| Combination | 56.18 | 0.9021(0.8581–0.9460) | 91.67 | 75.26 | 73.33 | 92.4 |